Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a birdflu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about ...
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...